Manners Technology announced that its entire range of Menchini liver biopsy needles has successfully passed the rigorous review of the new EU Medical Device Regulation (MDR) and has obtained dual certifications of ISO 9001:2015 and ISO 13485:2016 quality management systems based on the "zero defect" concept. The audit report particularly praised its full-process digital traceability system from raw material entry to finished product shipment, as well as the extraordinary cleanliness brought by electrolytic polishing and multi-level ultrasonic cleaning processes. This system ensures that the critical dimension tolerances of each biopsy needle leaving the factory are controlled within ±5 micrometers, and the biological load is lower than the industry standard by one order of magnitude, achieving the ultimate standardization of product reliability.

Research and Development Background and Challenges

Liver biopsy, as an invasive procedure, the reliability of the instruments directly affects patient safety. Under the traditional manufacturing model, quality risks are hidden in every step:

  Supply chain fluctuation risk: Minor differences in elemental content and grain size of different batches of raw materials may lead to unpredictable fluctuations in the performance of the final product;

  Process control blind spots: Traditional quality inspection relies on sampling, which cannot ensure absolute consistency of each product, especially for key but difficult-to-test parameters such as the microscopic geometric shape of the needle tip and the cleanliness of the inner cavity;

  Cleanliness risks: Residual processing oils, metal debris, or cleaning agents, if carried by the needle into the human body, may trigger inflammatory reactions, affect pathological judgment, and even lead to infection;

  Traceability difficulties: In the event of an adverse event, it is difficult to quickly and accurately locate the problem batch and the production process, which is not conducive to risk control.

Core Technological Innovation

The manufacturer has established a "digital quality closed-loop" system that covers the entire life cycle:

  Raw material traceability based on blockchain: Establish a unique digital identity code for all materials, especially the core steel that constitutes the "Bill of Materials (BOM)". This code links all information from the steel mill's melting number, chemical composition report, mechanical performance certificate to the data of each batch's in-warehouse inspection, and uploads it to a private blockchain to ensure that the data is immutable and fully traceable.

  Fully automatic online inspection and process control: Integrate machine vision systems and laser profilometers at key positions on the production line (such as after laser cutting and polishing), conducting 100% online inspection of the outer diameter, inner diameter, needle tip angle, and cutting edge defects of each needle. The data is uploaded in real time to the manufacturing execution system. Any deviation exceeding the statistical process control (SPC) limits will trigger an automatic alarm and isolate the product.

  Multi-level precise cleaning and cleanliness verification: Establish an automated cleaning line with the process of "chemical degreasing - electrolytic polishing - multi-frequency ultrasonic cleaning - ultra-pure water rinsing - vacuum drying". Electrolytic polishing not only removes microscopic burrs and smoothens the inner wall, but also forms a uniform passivation film that enhances corrosion resistance. The subsequent multi-frequency ultrasonic cleaning uses the cavitation effect of different frequencies to thoroughly remove contaminants adhering to the complex internal cavities in the corners. Cleanliness is verified through three methods: particle counting, endotoxin detection, and total organic carbon analysis.

Mechanism of Action

This quality system ensures reliability through the mechanism of "prevention first, full-process controllability, and data-driven approach":

Blockchain traceability locks the quality baseline from the source, transforming the "black box" of raw materials into a "white box". Any subsequent performance fluctuations can be traced back to the material batch, enabling root cause analysis.

100% online testing replaces traditional sampling inspection, eliminating the probability risk of "defective products slipping through the net". It is equivalent to establishing a complete "birth record" for each needle, with its size data bound to the serial number. In the future, it can be associated with clinical performance through big data analysis.

The synergy of electrolytic polishing and ultrasonic cleaning creates an ultra-clean surface at the physical and chemical levels. The chromium-enriched passivation layer formed by electrolytic polishing can effectively prevent the formation of biofilms. In the multi-frequency ultrasonic cleaning process, the low frequency (20-40kHz) generates large energy cavitation bubbles for the removal of large particle contaminants, while the high frequency (80-200kHz) generates dense small cavitation bubbles for cleaning sub-micron particles and residual biological molecules.

Efficacy Verification

This quality system has undergone rigorous internal verification and multiple on-site inspections by third-party certification bodies.

  Dimension consistency analysis: Key dimension measurements were conducted on 10,000 needles produced continuously. The calculated process capability index Cpk values were all greater than 2.0, indicating that the process was highly stable and the product dispersion was extremely low.

  Cleanliness limit test: According to the ISO 19227 (cleanliness standard for surgical implants) standard, the count results of particles (>10μm) in the inner cavity of the cleaned needles were far superior to the standard requirements, and the endotoxin content was lower than the detection limit of 0.01 EU/mL.

  Clinical feedback and traceability exercise: In the simulated product recall exercise, using the digital system, all production data, raw material batches, and inventory of any hypothetical defective product could be accurately identified within 15 minutes. During actual clinical use, no reportable adverse events related to product manufacturing defects occurred within three years.

Research and Development Strategy and Philosophy

Manas Technology's quality strategy is "Beyond compliance, pursue ultimate reliability". They believe that meeting ISO standards is merely the minimum requirement; the real goal is to achieve a quality level of Six Sigma (6σ) on an automated production line without any human intervention. Their core concept is "Quality is designed and manufactured, not inspected." Therefore, they invest a significant amount of resources in preventive quality engineering, such as using the Taguchi method to optimize the robustness of process parameters and using Failure Mode and Effects Analysis (FMEA) to identify potential risk points in advance. The quality department is not the final "gatekeeper", but rather a "designer" and "coach" throughout the entire process of research and development and production.

Future Outlook

The future quality system will evolve towards "predictive quality" and "adaptive manufacturing". Manufacturers are deploying "industrial Internet of Things platforms" to connect every piece of equipment and every sensor on the production line. By analyzing massive real-time production data through machine learning algorithms, the system can predict trends such as tool wear, laser power attenuation, or the decline in cleaning fluid efficacy, and automatically trigger maintenance or parameter adjustments before they affect product quality. Further, by combining clinical big data, in the future, it may achieve "process self-optimization based on clinical outcome feedback": if a batch of products shows a slight statistical decrease in tissue acquisition rate in multiple hospitals, the system can automatically analyze the production data of that batch, identify potential associated process parameters, and automatically adjust the subsequent production settings, forming an intelligent closed loop from clinical application to manufacturing process, continuously improving product performance.